Literature DB >> 23585642

Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum.

Edith A Nutescu1, Ann K Wittkowsky, Allison Burnett, Geno J Merli, Jack E Ansell, David A Garcia.   

Abstract

OBJECTIVE: To provide recommendations for optimized anticoagulant therapy in the inpatient setting and outline broad elements that need to be in place for effective management of anticoagulant therapy in hospitalized patients; the guidelines are designed to promote optimization of patient clinical outcomes while minimizing the risks for potential anticoagulation-related errors and adverse events. DATA SOURCES: The medical literature was reviewed using MEDLINE (1946-January 2013), EMBASE (1980-January 2013), and PubMed (1947-January 2013) for topics and key words including, but not limited to, standards of practice, national guidelines, patient safety initiatives, and regulatory requirements pertaining to anticoagulant use in the inpatient setting. Non-English-language publications were excluded. Specific MeSH terms used include algorithms, anticoagulants/administration and dosage/adverse effects/therapeutic use, clinical protocols/standards, decision support systems, drug monitoring/methods, humans, inpatients, efficiency/ organizational, outcome and process assessment (health care), patient care team/organization and administration, program development/standards, quality improvement/organization and administration, thrombosis/ drug therapy, thrombosis/prevention and control, risk assessment/standards, patient safety/standards, and risk management/methods. STUDY SELECTION AND DATA EXTRACTION: Because of this document's scope, the medical literature was searched using a variety of strategies. When possible, recommendations are supported by available evidence; however, because this paper deals with processes and systems of care, high-quality evidence (eg, controlled trials) is unavailable. In these cases, recommendations represent the consensus opinion of all authors and are endorsed by the Board of Directors of the Anticoagulation Forum, an organization dedicated to optimizing anticoagulation care. The board is composed of physicians, pharmacists, and nurses with demonstrated expertise and experience in the management of patients receiving anticoagulation therapy. DATA SYNTHESIS: Recommendations for delivering optimized inpatient anticoagulation therapy were developed collaboratively by the authors and are summarized in 8 key areas: (1) process, (2) accountability, (3) integration, (4) standards of practice, (5) provider education and competency, (6) patient education, (7) care transitions, and (8) outcomes. Recommendations are intended to inform the development of coordinated care systems containing elements with demonstrated benefit in improvement of anticoagulation therapy outcomes. Recommendations for delivering optimized inpatient anticoagulation therapy are intended to apply to all clinicians involved in the care of hospitalized patients receiving anticoagulation therapy.
CONCLUSIONS: Anticoagulants are high-risk medications associated with a significant rate of medication errors among hospitalized patients. Several national organizations have introduced initiatives to reduce the likelihood of patient harm associated with the use of anticoagulants. Health care organizations are under increasing pressure to develop systems to ensure the safe and effective use of anticoagulants in the inpatient setting. This document provides consensus guidelines for anticoagulant therapy in the inpatient setting and serves as a companion document to prior guidelines relevant for outpatients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23585642      PMCID: PMC3815430          DOI: 10.1345/aph.1R634

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  31 in total

1.  Adverse drug reactions in United States hospitals.

Authors:  C A Bond; Cynthia L Raehl
Journal:  Pharmacotherapy       Date:  2006-05       Impact factor: 4.705

2.  Medication errors associated with anticoagulant therapy in the hospital.

Authors:  John Fanikos; Carl Stapinski; Sophia Koo; Nils Kucher; Kanella Tsilimingras; Samuel Z Goldhaber
Journal:  Am J Cardiol       Date:  2004-08-15       Impact factor: 2.778

3.  Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.

Authors:  W E Dager; J M Branch; J H King; R H White; R S Quan; N A Musallam; T E Albertson
Journal:  Ann Pharmacother       Date:  2000-05       Impact factor: 3.154

Review 4.  Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance.

Authors:  Jennifer L Donovan; Julie A Drake; Peter Whittaker; Maichi T Tran
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

5.  The impact of computerized physician order entry on medication error prevention.

Authors:  D W Bates; J M Teich; J Lee; D Seger; G J Kuperman; N Ma'Luf; D Boyle; L Leape
Journal:  J Am Med Inform Assoc       Date:  1999 Jul-Aug       Impact factor: 4.497

6.  Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy.

Authors:  R F Ellis; M A Stephens; G B Sharp
Journal:  Am J Hosp Pharm       Date:  1992-02

7.  Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service.

Authors:  Christy Locke; Susan L Ravnan; Rajul Patel; James A Uchizono
Journal:  Pharmacotherapy       Date:  2005-05       Impact factor: 4.705

8.  Electronic alerts to prevent venous thromboembolism among hospitalized patients.

Authors:  Nils Kucher; Sophia Koo; Rene Quiroz; Joshua M Cooper; Marilyn D Paterno; Boris Soukonnikov; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

Review 9.  Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions.

Authors:  C A Bond; Cynthia L Raehl
Journal:  Pharmacotherapy       Date:  2004-08       Impact factor: 4.705

10.  Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.

Authors:  Suzan N Kucukarslan; Michael Peters; Mark Mlynarek; Daniel A Nafziger
Journal:  Arch Intern Med       Date:  2003-09-22
View more
  13 in total

Review 1.  Role of the anticoagulant monitoring service in 2018: beyond warfarin.

Authors:  Nathan P Clark
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Anticoagulation manager: development of a clinical decision support mobile application for management of anticoagulants.

Authors:  Pamela J Thompson; Julie R Taylor; Barbara A Zehnbauer; Karlyn K Wilson; May D Wang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2016-08

3.  An evidence-based standardized protocol for anticoagulation following congenital heart surgery.

Authors:  Catherine Deshaies; Nancy Poirier; Paul Khairy
Journal:  Transl Pediatr       Date:  2018-10

Review 4.  Regulatory, legislative, and policy updates with anticoagulant use.

Authors:  John Fanikos; Leo F Buckley; Ahmed Aldemerdash; Kimberly J Terry; Gregory Piazza; Jean M Connors; Samuel Z Goldhaber
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

5.  The scope and value of an anticoagulation stewardship program at a community teaching hospital.

Authors:  Maura K Wychowski; Christina I Ruscio; Peter A Kouides; Ronald L Sham
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

6.  Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge.

Authors:  Nibal Chamoun; C Gabriela Macías; Jennifer L Donovan; Robert Klugman; Joel Gore; Pascale Salameh; Maichi T Tran
Journal:  J Thromb Thrombolysis       Date:  2017-05       Impact factor: 2.300

Review 7.  The future of inpatient anticoagulation management.

Authors:  Allison E Burnett; Toby C Trujillo
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

8.  Preemptive warfarin dose reduction after initiation of sulfamethoxazole-trimethoprim or metronidazole.

Authors:  Anna Powers; Erin B Loesch; Anthony Weiland; Nicole Fioravanti; David Lucius
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

9.  [New oral anticoagulants in perioperative medicine].

Authors:  A Giebl; K Gürtler
Journal:  Anaesthesist       Date:  2014-04       Impact factor: 1.041

10.  Meaningful use of health information technology and declines in in-hospital adverse drug events.

Authors:  Michael F Furukawa; William D Spector; M Rhona Limcangco; William E Encinosa
Journal:  J Am Med Inform Assoc       Date:  2017-07-01       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.